Test helps doctors decide who needs chemo
NCT ID NCT03961880
Summary
This study looked at how doctors use a specific genetic test (OncotypeDX) to make decisions about chemotherapy for patients with early-stage, hormone-positive breast cancer. It involved 270 women and observed how the test's 'Recurrence Score' influenced treatment recommendations. The research also explored how this score related to other factors like age and whether cancer cells had spread to the bone marrow.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER - FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department for Women's Health
Tübingen, Baden-Wurttemberg, 72086, Germany
Conditions
Explore the condition pages connected to this study.